Intact proviral DNA assay analysis of large cohorts of people with HIV provides a benchmark for the frequency and composition of persistent proviral DNA
暂无分享,去创建一个
R. Siliciano | L. Montaner | J. Blankson | J. Siliciano | J. Mellors | S. Deeks | B. Howell | R. Gandhi | G. Laird | C. Tumiotto | F. Simonetti | M. Cai | J. White | K. Ritter | Albine Martin
[1] D. Richman,et al. Intact HIV reservoir estimated by the intact proviral DNA assay correlates with levels of total and integrated DNA in the blood during suppressive antiretroviral therapy. , 2020, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[2] Richard D Moore,et al. Longitudinal study reveals HIV-1-infected CD4+ T cell dynamics during long-term antiretroviral therapy. , 2020, The Journal of clinical investigation.
[3] J. Blankson,et al. A Comparison of Different Immune Activation Strategies to Reverse HIV-1 Latency , 2020, Open forum infectious diseases.
[4] R. Siliciano,et al. Differential decay of intact and defective proviral DNA in HIV-1-infected individuals on suppressive antiretroviral therapy. , 2020, JCI insight.
[5] B. Sherman,et al. Defective HIV-1 proviruses produce viral proteins , 2020, Proceedings of the National Academy of Sciences.
[6] R. Siliciano,et al. Different human resting memory CD4+ T cell subsets show similar low inducibility of latent HIV-1 proviruses , 2020, Science Translational Medicine.
[7] J. Blankson,et al. Elite suppressors have low frequencies of intact HIV-1 proviral DNA. , 2019, AIDS.
[8] Taina T. Immonen,et al. Principles Governing Establishment versus Collapse of HIV-1 Cellular Spread. , 2019, Cell host & microbe.
[9] R. Siliciano,et al. The Landscape of Persistent Viral Genomes in ART-Treated SIV, SHIV, and HIV-2 Infections. , 2019, Cell host & microbe.
[10] R. Siliciano,et al. A novel quantitative approach for measuring the reservoir of latent HIV-1 proviruses , 2019, Nature.
[11] R. Siliciano,et al. A novel quantitative approach for measuring the reservoir of latent HIV-1 proviruses , 2019, Nature.
[12] Jeffrey M. Gerold,et al. Expanded cellular clones carrying replication-competent HIV-1 persist, wax, and wane , 2018, Proceedings of the National Academy of Sciences.
[13] E. Boritz,et al. Identification of Genetically Intact HIV-1 Proviruses in Specific CD4+ T Cells from Effectively Treated Participants. , 2017, Cell reports.
[14] D. Kaufmann,et al. Multiparametric characterization of rare HIV-infected cells using an RNA-flow FISH technique , 2017, Nature Protocols.
[15] D. Hazuda,et al. HDAC inhibition induces HIV-1 protein and enables immune-based clearance following latency reversal. , 2017, JCI insight.
[16] Mary K. Lewinski,et al. Relative efficacy of T cell stimuli as inducers of productive HIV-1 replication in latently infected CD4 lymphocytes from patients on suppressive cART. , 2017, Virology.
[17] E. Rosenberg,et al. Clonal expansion of genome-intact HIV-1 in functionally polarized Th1 CD4+ T cells , 2017, The Journal of clinical investigation.
[18] R. Siliciano,et al. Defective HIV-1 Proviruses Are Expressed and Can Be Recognized by Cytotoxic T Lymphocytes, which Shape the Proviral Landscape. , 2017, Cell host & microbe.
[19] Daniel I. S. Rosenbloom,et al. Proliferation of latently infected CD4+ T cells carrying replication-competent HIV-1: Potential role in latent reservoir dynamics , 2017, The Journal of experimental medicine.
[20] S. Hughes,et al. Proviruses with identical sequences comprise a large fraction of the replication-competent HIV reservoir , 2017, PLoS pathogens.
[21] A. Chakraborty,et al. Paired quantitative and qualitative assessment of the replication-competent HIV-1 reservoir and comparison with integrated proviral DNA , 2016, Proceedings of the National Academy of Sciences.
[22] R. Dewar,et al. Defective HIV-1 proviruses produce novel protein-coding RNA species in HIV-infected patients on combination antiretroviral therapy , 2016, Proceedings of the National Academy of Sciences.
[23] R. Siliciano,et al. Defective proviruses rapidly accumulate during acute HIV-1 infection , 2016, Nature Medicine.
[24] S. Hughes,et al. Clonally expanded CD4+ T cells can produce infectious HIV-1 in vivo , 2016, Proceedings of the National Academy of Sciences.
[25] Nancie M Archin,et al. Precise Quantitation of the Latent HIV-1 Reservoir: Implications for Eradication Strategies. , 2015, The Journal of infectious diseases.
[26] D. Hazuda,et al. A Novel Assay to Measure the Magnitude of the Inducible Viral Reservoir in HIV-infected Individuals , 2015, EBioMedicine.
[27] Brendan B. Larsen,et al. Proliferation of cells with HIV integrated into cancer genes contributes to persistent infection , 2014, Science.
[28] S. Hughes,et al. Specific HIV integration sites are linked to clonal expansion and persistence of infected cells , 2014, Science.
[29] Sarah B. Laskey,et al. Replication-Competent Noninduced Proviruses in the Latent Reservoir Increase Barrier to HIV-1 Cure , 2013, Cell.
[30] R. Siliciano,et al. Comparative Analysis of Measures of Viral Reservoirs in HIV-1 Eradication Studies , 2013, PLoS pathogens.
[31] J. Karn,et al. Establishment of HIV Latency in Primary CD4+ Cells Is due to Epigenetic Transcriptional Silencing and P-TEFb Restriction , 2010, Journal of Virology.
[32] Tina Lenasi,et al. Transcriptional interference antagonizes proviral gene expression to promote HIV latency. , 2008, Cell host & microbe.
[33] R. Siliciano,et al. Orientation-dependent regulation of integrated HIV-1 expression by host gene transcriptional readthrough. , 2008, Cell host & microbe.
[34] Reuben S. Harris,et al. Retroviral restriction by APOBEC proteins , 2004, Nature Reviews Immunology.
[35] R. Siliciano,et al. Long-term follow-up studies confirm the stability of the latent reservoir for HIV-1 in resting CD4+ T cells , 2003, Nature Medicine.
[36] E. Verdin,et al. HIV reproducibly establishes a latent infection after acute infection of T cells in vitro , 2003, The EMBO journal.
[37] M. Malim,et al. Isolation of a human gene that inhibits HIV-1 infection and is suppressed by the viral Vif protein , 2002, Nature.
[38] J. Lisziewicz,et al. Latent infection of CD4+ T cells provides a mechanism for lifelong persistence of HIV-1, even in patients on effective combination therapy , 1999, Nature Medicine.
[39] M A Nowak,et al. Presence of an inducible HIV-1 latent reservoir during highly active antiretroviral therapy. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[40] D. Richman,et al. Recovery of replication-competent HIV despite prolonged suppression of plasma viremia. , 1997, Science.
[41] R Brookmeyer,et al. Identification of a reservoir for HIV-1 in patients on highly active antiretroviral therapy. , 1997, Science.